CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
Yamamoto Y, Sugimoto A, Maruo K, Tsujio G, Sera T, Kushiyama S, Nishimura S, Kuroda K, Togano S, Eguchi S, Tanaka R, Kimura K, Amano R, Ohira M, Yashiro M.
Yamamoto Y, et al. Among authors: eguchi s.
PLoS One. 2022 Apr 4;17(4):e0266027. doi: 10.1371/journal.pone.0266027. eCollection 2022.
PLoS One. 2022.
PMID: 35377900
Free PMC article.